K974552 is an FDA 510(k) clearance for the DIAMEDIX IS-MEASLES IGG TEST SYSTEM. This device is classified as a Enzyme Linked Immunoabsorbent Assay, Rubeola Igg (Class I — General Controls, product code LJB).
Submitted by Diamedix Corp. (Miami, US). The FDA issued a Cleared decision on January 28, 1998, 55 days after receiving the submission on December 4, 1997.
This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.3520. The Qualitative Detection Of Measles Specific Igg Antibodies In Serum Or Plasma..